Insider buying last 90 days
No open-market insider purchases were filed for ACT in the last 90 days.
From Form 4 filings, dated to when each was filed.
Enact's third-quarter results dominate this week's news, with revenue of $312.9 million roughly flat year-on-year and missing the consensus estimate of $317.9 million, while non-GAAP profit of $1.19 per share came in line with expectations. Net income fell to $158.9 million from $163.5 million a year earlier, even as the dividend was raised to $0.24 and 2026 capital return guidance was lifted to approximately $600 million. Adjusted operating income reached $164 million with a 12% return on equity, and the quarter's earnings call followed a separate report of an executive order aimed at lowering homeownership costs, a development being watched for its potential effect on the mortgage insurance sector. Analysts have since published new forecasts following the results.
Shares closed at $46.71, up 0.6%, sitting between the 50-day average of $47.33 and the 200-day average of $44.59. The GekkoIndex reads 59.6, placing the stock in the Neutral zone, and the price sits 1.2% below Gekko Fair Value of $47.3. The one-year return stands at 27.1%, though the three-month return is -4.9%.
The next earnings date falls on 2 February 2027, 84 days out and beyond a typical 20-trading-day holding window. No insider, Congress, or unusual options activity appears in the current window. Seasonality is a point worth noting: over the past 5 years, the next 20 trading days from this point averaged -2.3%, rising in only 2 of those years. Analyst coverage currently shows 0 buy, 3 hold, and 2 sell ratings, with a consensus target of $47.2.
Written by AI from the Nov 9, 2026 close and checked automatically against the figures on this page.
Enact scores 2 supportive, 2 mixed and 1 headwind across the 5 checklist items with data.
Six things swing traders check before a 20-day hold, read from the latest data.
2 supportive2 mixed1 headwind
Averages disagree
Close $45.39 sits between the 50-day ($47.10) and 200-day ($44.72) averages, or the averages disagree.
See the chart64.5, Accumulation
Reading 64.5 is in the Accumulation zone.
See the GekkoIndex3.5% below
Price is within 5% of Gekko Fair Value (3.5% below).
See fair valueNo data
No insider, Congress or unusual options activity in the window.
See smart moneyReports in 79 days
Next report Feb 2, 2027, 79 days away — outside a typical 20-trading-day hold.
See earnings−1.3% on average
From this point in the calendar, the next 20 trading days averaged −1.3% over 5 years, rising in 2 of them.
See seasonalityA description of current data, not a recommendation. How this page works
Enact closed at $45.39 on Nov 13, 2026, +20.6% over the past year, inside a 52-week range of $36.77 to $50.56.
Use the left and right arrow keys to read daily values.
Put ACT on a Gekko watchlist and see its GekkoIndex, Gekko Fair Value and smart money signals update on the chart as they change.
Enact provides mortgage insurance to lenders across the United States, covering residential home loans against borrower default. Its coverage centers on private mortgage insurance for prime-quality, individually underwritten loans, and it is recognized for this core guaranty insurance business alongside pool insurance policies that cover groups of loans.
Beyond writing and assuming mortgage guaranty insurance, Enact provides contract underwriting support and reinsurance products tied to mortgage risk. Its customer base spans large money center banks, non-bank lenders, mortgage bankers working at both national and local levels, community banks, and credit unions, reflecting a reach across different scales of mortgage lending.
Enact was established in 1981 and operates out of Raleigh, North Carolina. Its shares trade on the NASDAQ under the ticker ACT.
Enact’s GekkoIndex — Gekko’s 0 to 100 smart money score — reads 64.5, in the Accumulation zone, up 4.4 points over five sessions.
Up 4.4 points over five sessions.
Reading for Nov 13, 2026
| Zone | Readings | 5 days | 20 days |
|---|---|---|---|
| Buying | 22 | +1.6% | +5.7% |
| Accumulation (current zone) | 157 | +0.6% | +4.8% |
| Neutral | 478 | +0.4% | +0.8% |
| Distribution | 34 | −0.6% | −0.7% |
| Selling | 11 | +0.2% | −4.5% |
Average ACT share-price change over the trading days after each daily reading in its GekkoIndex history. Across every stock Gekko tracks, Accumulation readings averaged +2.0% over 20 days. Past behaviour doesn’t guarantee future results.
Accumulation zone: Institutional interest building. About the five zones →
Enact trades 3.5% below Gekko Fair Value of $47.06, so the shares are about fair value on Gekko’s estimate.
Gekko’s own estimate of what Enact shares are worth, recalculated every trading day.
$47.06
Gekko Fair Value, Nov 14, 2026
3.5% below fair value · About fair value
At the end of Aug 2026 the price was 1.9% below the estimate.
No open-market insider purchases were filed for Enact, and no Congress trades were disclosed, in the last 90 days.
Plus buybacks, unusual options and fund positions, each dated to when it became public.
No open-market insider purchases were filed for ACT in the last 90 days.
From Form 4 filings, dated to when each was filed.
No trades in ACT were disclosed by members of Congress in the last 90 days.
From congressional disclosures, which report amounts as ranges.
Enact has been buying back its own shares.
From company filings.
Enact reports on Feb 2, 2027 (79 days away).
Feb 2, 2027
79 days away
Analysts’ average 12-month price target for Enact is $47.00, +3.5% from the last close, from 5 firms rating the stock in the last 90 days.
Each firm’s latest rating in the last 90 days: 5 firms.
| Date | Firm | Target | vs price |
|---|---|---|---|
| Nov 8 | Bank of America Securities | $40 | −11.9% |
| Nov 6 | KBW | $49 | +8.0% |
| Nov 6 | J.P. Morgan | $45 | −0.9% |
| Nov 5 | RBC Capital | $50 | +10.2% |
| Oct 30 | Bank of America Securities | $42 | −7.5% |
Gekko doesn’t publish price predictions. These are analyst targets and historical base rates, which don’t guarantee future results.
Over the next 20 trading days from Nov 14, Enact averaged −1.3% across the last 5 years, rising in 2 of them.
| Window | Average | Years higher |
|---|---|---|
| Next 5 trading days | −1.0% | 2 of 5 |
| Next 10 trading days | −2.1% | 2 of 5 |
| Next 15 trading days | −2.8% | 2 of 5 |
| Next 20 trading days | −1.3% | 2 of 5 |
| Next 30 trading days | −3.0% | 2 of 5 |
For scale, ACT’s typical 20-trading-day move in either direction is about 4.3%.
Enact’s market cap is $6.10B, with a P/E ratio of 9.6 and revenue of $1.25B over the last twelve months.
Coverage of Enact this week reads neutral: 0 positive, 4 neutral and 2 negative headlines.
Enact’s 6 largest industry peers by market value, with today’s move, GekkoIndex zone and gap to Gekko Fair Value.
| Stock | GekkoIndex zone | vs Fair Value |
|---|---|---|
| PGRProgressive | Neutral | 4.8% above |
| MFCManulife Financial | Neutral | 9.7% above |
| ALLAllstate | Neutral | 3.5% above |
| METMetLife | Neutral | 0.8% below |
| AFLAFLAC | Neutral | 7.6% above |
| AIGAIG | Neutral | 0.8% above |
A peer links to its own page where one exists.
Enact’s market cap is $6.10B at the Nov 13, 2026 close of $45.39, with 134.4M shares outstanding. The shares trade on a P/E ratio of 9.6.
The consensus analyst 12-month price target for Enact is $47.00, +3.5% from the last close. Of the 5 firms that rated the stock in the last 90 days, 0 rate it a buy, 3 a hold and 2 a sell. Gekko doesn’t publish price predictions of its own.
On Gekko’s estimate Enact is about fair value: the Nov 13, 2026 close of $45.39 is 3.5% below Gekko Fair Value of $47.06. Gekko Fair Value is recalculated every trading day, and a gap inside 5% either way counts as about fair value.
Enact is expected to report on Feb 2, 2027 (79 days away). Analysts expect earnings of $1.17 per share on revenue of $317.3M.
Enact’s 52-week high is $50.56 and its 52-week low is $36.77; it closed at $45.39 on Nov 13, 2026, +20.6% over the past year.
Gekko describes the data; it does not make buy or sell recommendations. On the swing-trade checklist, 2 of the 5 items with data read as supportive (gekkoindex and earnings risk), 2 as mixed (trend and fair value) and 1 as a headwind (seasonality). The checklist is a description of current data, not a recommendation.
During US trading hours the price at the top of the page is a delayed quote, refreshed every 15 minutes; everything else is rebuilt after each US market close. The GekkoIndex, Gekko Fair Value and the checklist are Gekko’s own, and the Gekko Brief is written by AI from this page’s data and checked against it before it is published. How Gekko’s data works →
Every GekkoIndex reading, insider trade, options bet and Congress disclosure plotted on the chart, plus the 5,800-name screener and trade planning tools.
Join 1,475 other traders using Gekko
Start Your FREE 7 Day Trial → Every feature unlocked. No credit card required.Type a ticker or company name. Press Esc to close.